Beata K. K.
- Country
- Poland
- Department
- Department of Endocrinology and Neuroendocrine Tumor
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Evaluation of Batoclimab Efficacy and Safety in an Open-Label Extension Study for Thyroid Eye Disease Treatment in Participants Completing IMVT-1401-3201/3202
- Phase 3 Randomized Quadruple-Masked Placebo-Controlled Trial of Batoclimab in Active Thyroid Eye Disease Patients
Data & Insights
Has run more than one trial at 58 of 147 partner sites.
Specializations
Ophthalmologic Disorders
This investigator specializes in the treatment of Thyroid Eye Disease (TED), focusing on innovative therapeutic approaches for this challenging ophthalmologic condition.
- Orbital Eye Disorders
- Autoimmune Eye Conditions
- Vision-threatening Eye Disease
The research encompasses the evaluation of advanced treatment options for managing orbital inflammation and proptosis in TED patients.
Endocrine Ophthalmology
Expertise in treating thyroid-related eye complications, with particular attention to the intersection of endocrine disorders and ocular manifestations.
- Thyroid-Associated Eye Disease
- Orbital Inflammation
- Proptosis Management
The investigator focuses on developing long-term therapeutic strategies for patients with active and chronic TED.
Therapeutic Innovation
Active involvement in evaluating novel biological therapies for the treatment of orbital inflammatory conditions.
- Targeted Immunotherapy
- Long-term Disease Management
- Treatment Response Assessment
Specializes in investigating maintenance therapies and treatment efficacy in orbital inflammatory disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.